The partnerships allow Bionovis to receive cutting-edge technology and training and be trained, in the short term, to work in the production and commercialization of highly complex biological and biosimilar medicines.
Bionovis operates in the prospection of products and scientific resources for licensing and technology transfer and is qualified to develop new drugs, in addition to being a partner in the production of drugs for clinical studies or on an industrial scale.
Bionovis focuses on the development, production and commercialization of biopharmaceuticals. To this end, the company identifies molecules of interest, aiming to develop and make them available to the national and international market through various partnership formats.
We work on prospecting products for licensing with or without technology transfer. Using this model, products can be manufactured by Bionovis and sold in the private system.
Bionovis focuses on the development, production and commercialization of biopharmaceuticals.
To this end, the company identifies molecules of interest, aiming to develop and make them available to the national and international market through various partnership formats.
Developing a new drug is a process that can take decades of research and cost hundreds of millions of dollars in research.
Therefore, Bionovis seeks partners to join efforts in the production of new medicines.
Contract Manufacturing Organizations (CMO) allow pharmaceutical companies to outsource some aspects of their business, such as the manufacturing processes for biopharmaceuticals on a commercial scale or clinical batches for scientific trials. Bionovis offers these services at its industrial plant, located in Valinhos/SP.
We are motivated by the pride of being part of the transformation in health in Brazil.
Being a Bionovis partner means investing in Brazil’s self-sufficiency, in the generation of jobs and income and in the democratization of access to healthcare for the entire population.
Bionovis Team
Over more than a decade of operation, we have built partnerships with major global leaders in the pharmaceutical sector and public laboratories, such as: Bio-Manguinhos/FIOCRUZ, Fresenius Kabi, Johnson & Johnson Innovative Medicine, Merck, Samsung Bioepis and Sandoz.
Through these partnerships, we receive the complete technology for the production of innovative biopharmaceuticals and biosimilars.
In addition, we have signed partnerships for commercialization in the private market, with INTAS and mAbxience.
Bionovis is a pioneer in the production and commercialization of biological and biosimilar medicines.
Our search for scientific innovations and highly complex medicines aims to build a healthier Brazil and world for everyone.
© 2025 Bionovis. Companhia Brasileira de Biotecnologia Farmacêutica.
